These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32286943)
1. Anti-DENV and Anti-Dengue Vector Activity of Some Heterocyclic Scaffolds. Purohit D; Dhingra N; Dutt R; Kumar S Mini Rev Med Chem; 2020; 20(12):1062-1071. PubMed ID: 32286943 [TBL] [Abstract][Full Text] [Related]
2. The search for nucleoside/nucleotide analog inhibitors of dengue virus. Chen YL; Yokokawa F; Shi PY Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002 [TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of ST081006 against the dengue virus. Lee JK; Chui JLM; Lee RCH; Kong HY; Chin WX; Chu JJH Antiviral Res; 2019 Nov; 171():104589. PubMed ID: 31421165 [TBL] [Abstract][Full Text] [Related]
4. Diterpenes and their derivatives as promising agents against dengue virus and dengue vectors: A literature-based review. Islam MT; Mubarak MS Phytother Res; 2020 Apr; 34(4):674-684. PubMed ID: 31802573 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents. Lin C; Yu J; Hussain M; Zhou Y; Duan A; Pan W; Yuan J; Zhang J Antiviral Res; 2018 Jan; 149():95-105. PubMed ID: 29129706 [TBL] [Abstract][Full Text] [Related]
6. Seeking heterocyclic scaffolds as antivirals against dengue virus. De S; Aamna B; Sahu R; Parida S; Behera SK; Dan AK Eur J Med Chem; 2022 Oct; 240():114576. PubMed ID: 35816877 [TBL] [Abstract][Full Text] [Related]
7. An iminosugar with potent inhibition of dengue virus infection in vivo. Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological intervention for dengue virus infection. Lai JH; Lin YL; Hsieh SL Biochem Pharmacol; 2017 Apr; 129():14-25. PubMed ID: 28104437 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticles in the fight against mosquito-borne diseases: bioactivity of Bruguiera cylindrica-synthesized nanoparticles against dengue virus DEN-2 (in vitro) and its mosquito vector Aedes aegypti (Diptera: Culicidae). Murugan K; Dinesh D; Paulpandi M; Althbyani AD; Subramaniam J; Madhiyazhagan P; Wang L; Suresh U; Kumar PM; Mohan J; Rajaganesh R; Wei H; Kalimuthu K; Parajulee MN; Mehlhorn H; Benelli G Parasitol Res; 2015 Dec; 114(12):4349-61. PubMed ID: 26290219 [TBL] [Abstract][Full Text] [Related]
11. Novel concept on antiviral strategies to dengue. Lo YC; Perng GC Curr Opin Virol; 2016 Jun; 18():97-108. PubMed ID: 27284691 [TBL] [Abstract][Full Text] [Related]
12. Management and Treatment of Dengue and Chikungunya - Natural Products to the Rescue. Suroowan S; Mahomoodally F; Ragoo L Comb Chem High Throughput Screen; 2016; 19(7):554-64. PubMed ID: 27151484 [TBL] [Abstract][Full Text] [Related]
13. Dengue in the Middle East and North Africa: A Systematic Review. Humphrey JM; Cleton NB; Reusken CB; Glesby MJ; Koopmans MP; Abu-Raddad LJ PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005194. PubMed ID: 27926925 [TBL] [Abstract][Full Text] [Related]
15. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050 [TBL] [Abstract][Full Text] [Related]
16. The spatial and temporal scales of local dengue virus transmission in natural settings: a retrospective analysis. Sedda L; Vilela APP; Aguiar ERGR; Gaspar CHP; Gonçalves ANA; Olmo RP; Silva ATS; de Cássia da Silveira L; Eiras ÁE; Drumond BP; Kroon EG; Marques JT Parasit Vectors; 2018 Feb; 11(1):79. PubMed ID: 29394906 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX. Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117 [TBL] [Abstract][Full Text] [Related]
18. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143 [TBL] [Abstract][Full Text] [Related]
19. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target. Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774 [TBL] [Abstract][Full Text] [Related]
20. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS; Wu KX; Chen KC; Ng MM; Chu JJ Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]